Stay updated on GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial

Sign up to get notified when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision v3.4.2 was added to the history; the prior funding notice and v3.4.1 entry were removed.
    Difference
    0.8%
    Check dated 2026-02-11T02:33:31.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added a site-wide notice regarding government funding delays and updated the revision from v3.4.0 to v3.4.1.
    Difference
    0.8%
    Check dated 2026-02-03T23:44:29.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option, color-coded highlights for additions (green) and deletions (red) in the study history, and a revision note showing v3.4.0 replacing v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-27T20:55:01.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no changes to study data or page content, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-20T15:34:50.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The record now shows Active, not recruiting and an updated title reflecting Relapse/Refractory AML. It also adds new sections including IPDSharing, Contacts/Locations, Study Design, Conditions, Study Description, Oversight, Sponsor/Collaborators, and Recruitment Status.
    Difference
    2%
    Check dated 2026-01-06T03:21:04.000Z thumbnail image
  9. Check
    74 days ago
    Change Detected
    Summary
    Added a new revision entry (Revision: v3.3.3) to the study's Record History. Removed the HHS Vulnerability Disclosure item and Revision: v3.3.2.
    Difference
    0.2%
    Check dated 2025-12-22T23:56:21.000Z thumbnail image

Stay in the know with updates to GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.